Teladoc Health, Inc.
TDOC
$6.36
-$0.25-3.78%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -171.15M | -200.32M | -223.59M | -207.36M | -1.01B |
| Total Depreciation and Amortization | 216.65M | 208.82M | 204.88M | 210.96M | 228.46M |
| Total Amortization of Deferred Charges | 163.80M | 167.62M | 164.00M | 157.59M | 144.05M |
| Total Other Non-Cash Items | 72.72M | 117.17M | 139.50M | 144.09M | 965.43M |
| Change in Net Operating Assets | 5.93M | 1.08M | 7.72M | -1.85M | -24.90M |
| Cash from Operations | 287.95M | 294.36M | 292.52M | 303.43M | 300.68M |
| Capital Expenditure | -7.83M | -8.89M | -12.41M | -11.72M | -12.37M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -17.30M | -81.90M | -81.90M | -65.30M | -64.61M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -154.13M | -175.21M | -167.02M | -166.73M | -134.83M |
| Cash from Investing | -179.26M | -266.00M | -261.33M | -243.76M | -211.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -550.63M | -550.63M | -550.63M | -550.63M | -- |
| Issuance of Common Stock | 2.72M | 3.09M | 3.86M | 4.30M | 7.44M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.96M | -4.11M | -3.93M | -83.00K | -106.00K |
| Cash from Financing | -554.87M | -551.65M | -550.70M | -546.41M | 7.33M |
| Foreign Exchange rate Adjustments | 3.58M | 6.06M | 1.89M | 3.97M | -804.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -442.59M | -517.24M | -517.62M | -482.76M | 95.40M |